Skip to main content

We are delighted to announce AGC Pharma Chemicals’ participation in BOS Basel, scheduled for June 19th to 20th in Basel, Switzerland.

BOS Basel’s scope is primarily development stage CMC outsourcing for Small Molecules. This means it offers a unique opportunity to connect with specialized experts and decision-makers in the field.

As a CDMO, at AGC Pharma Chemicals, we excel in providing comprehensive solutions for Small Molecules development and manufacturing. Our presence at BOS Basel will focus on our extensive experience in process development, scalable API life cycle management, and our state-of-the-art technology portfolio. We are dedicated to offering excellent, agile, and innovative processes, from raw material sourcing to final product delivery, ensuring your projects achieve success in a cost-effective manner.

Visit our booth 12 at BOS Basel to discover how we can enhance your biopharmaceutical projects with our approaches and expertise!

Latest News

Events & ConventionsAGC Pharma Chemicals to Attend the 54th Organic Process Research & Development Conference in Lisbon
26th September 2025

AGC Pharma Chemicals to Attend the 54th Organic Process Research & Development Conference in Lisbon

AGC Pharma Chemicals will be attending the 54th Organic Process Research and Development Conference in Lisbon from September 29 to October 1, 2025. This premier gathering of process chemists and…
NoticiasAGC Pharma Chemicals inaugurates a new advanced manufacturing plant in Malgrat de Mar (Barcelona), with an investment of over 100 million euros
25th September 2025

AGC Pharma Chemicals inaugurates a new advanced manufacturing plant in Malgrat de Mar (Barcelona), with an investment of over 100 million euros

AGC Pharma Chemicals inaugurated its new state-of-the-art manufacturing plant in Malgrat de Mar, Barcelona, representing an investment of over 100 million euros. The new facility marks a key milestone in…
All of ArticlesCDMO ProcessesThe Power of Small Particles: Understanding Micronization in Small Molecule APIs
26th June 2025

The Power of Small Particles: Understanding Micronization in Small Molecule APIs

Did you know that over 70% of new drug molecules face significant bioavailability challenges? The Paradigm Shift in Pharma With over 30% of active pharmaceutical ingredients (APIs) requiring micronization and…